Recently, Zacks.com users have been paying close attention to InMode (INMD). This makes it worthwhile to examine what the stock has in store.
Zacks.com users have recently been watching InMode (INMD) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
The stock market is filled with sleeper stocks that present tempting opportunities. Some investment ideas receive much of the spotlight.
Zacks.com users have recently been watching InMode (INMD) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Forever stocks can be tough picks in today's market. The stock market goes through many twists and turns.
InMode continues to steadily expand its base of revenue and its market penetration. It's also becoming more profitable over time while growing.

This 1 Number Shows Why InMode Stock Is a Buy

10:12am, Wednesday, 09'th Aug 2023
InMode's customers need to buy consumable products to use with their devices. The more consumables the company sells, the more recurring revenue it gets.

Is It Too Late to Buy InMode Stock?

05:39am, Sunday, 30'th Jul 2023
InMode shares rose sharply in anticipation of the company's second-quarter earnings report. Soaring sales of medical devices used for minimally invasive cosmetic procedures drove profits 25% higher ye
InMode's sales performance has been strong, and it might get still stronger soon. Popular weight-loss drugs could lead to more demand for skin tightening services.
InMode (INMD) came out with quarterly earnings of $0.72 per share, beating the Zacks Consensus Estimate of $0.70 per share. This compares to earnings of $0.59 per share a year ago.
Zacks.com users have recently been watching InMode (INMD) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Why InMode Stock Flew to a New 52-Week High Today

04:40pm, Wednesday, 12'th Jul 2023
InMode released preliminary financial results that were better than what analysts expected, and management raised its full-year guidance as a result. The company has surprised the market with finalize
Investors seeking higher returns on their capital often turn to hypergrowth stocks. These assets have great potential and can comfortably exceed the returns of the S&P 500 if the companies continue to
InMode Ltd.'s stock INMD, +2.31% rose 2.5% premarket Wednesday, after the Israeli medical tech company offered second-quarter guidance that topped estimates and raised its full-year revenue guidance.

InMode: No Respect - Take Off Soon

09:00am, Tuesday, 11'th Jul 2023
InMode's valuations have been discounted drastically compared to its 3Y means and its peers, suggesting its overly depressed price target of $48.30. However, we believe an upward revision to P/E of 18
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE